Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Barinthus Biotherapeutics plc - American Depositary Shares (NQ:BRNS)

1.420 -0.075 (-5.02%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 102,359
Open 1.490
Bid (Size) 1.400 (20)
Ask (Size) 1.580 (3)
Prev. Close 1.495
Today's Range 1.390 - 1.550
52wk Range 0.6400 - 2.920
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
BRNS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Barinthus Biotherapeutics plc Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire

Performance

YTD
+14.5%
+14.5%
1 Month
+21.1%
+21.1%
3 Month
+54.2%
+54.2%
6 Month
+86.8%
+86.8%
1 Year
+18.3%
+18.3%

More News

Read More
Barinthus Biotherapeutics To Merge With Privately-Held Clywedog Therapeutics
Via Stocktwits
Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases
From Barinthus Biotherapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments
From Barinthus Biotherapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Which stocks are experiencing notable movement on Monday?
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
US Stocks Mixed; Bank of America Earnings Top Views
Via Benzinga
Q2 Virtual Investor Summit: Presentations Available Now
Via ACCESS Newswire
Barinthus Biotherapeutics' CEO Bill Enright to Present at the Investor Summit Virtual on June 10, 2025
Via ACCESS Newswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments
From Barinthus Biotherapeutics
Via GlobeNewswire
Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments
From Barinthus Biotherapeutics
Via GlobeNewswire
Q1 Virtual Investor Summit: On-Demand Presentations Now Live
Via ACCESS Newswire
Barinthus Biotherapeutics plc to Present at the Investor Summit Virtual on March 11
Via ACCESS Newswire
Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update
From Barinthus Biotherapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Barinthus Bio Promotes SNAP-TI Co-inventor, Geoffrey Lynn, M.D., Ph.D. to Chief Scientific Officer
From Barinthus Biotherapeutics
Via GlobeNewswire
Barinthus Bio Announces Results From Ongoing Phase 2b Chronic Hepatitis B Trial, Including Achievement of Functional Cure and HBsAb Seroconversion
From Barinthus Biotherapeutics
Via GlobeNewswire
Arbutus and Barinthus Bio Announce New Data from the IM-PROVE II Trial Showing that the Addition of Nivolumab Increased Rates of HBsAg Loss in People with Chronic Hepatitis B
From Barinthus Biotherapeutics
Via GlobeNewswire
Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results
From Barinthus Biotherapeutics
Via GlobeNewswire
Barinthus Bio Announces Late Breaking Presentation at AASLD 2024 – The Liver Meeting® and Attendance at November Conferences
From Barinthus Biotherapeutics
Via GlobeNewswire

Frequently Asked Questions

Is Barinthus Biotherapeutics plc - American Depositary Shares publicly traded?
Yes, Barinthus Biotherapeutics plc - American Depositary Shares is publicly traded.
What exchange does Barinthus Biotherapeutics plc - American Depositary Shares trade on?
Barinthus Biotherapeutics plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Barinthus Biotherapeutics plc - American Depositary Shares?
The ticker symbol for Barinthus Biotherapeutics plc - American Depositary Shares is BRNS on the Nasdaq Stock Market
What is the current price of Barinthus Biotherapeutics plc - American Depositary Shares?
The current price of Barinthus Biotherapeutics plc - American Depositary Shares is 1.420
When was Barinthus Biotherapeutics plc - American Depositary Shares last traded?
The last trade of Barinthus Biotherapeutics plc - American Depositary Shares was at 10/02/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.